Monday, May 3, 2010

Vol. 16, No. 9

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 16, No. 9  May 3, 2010
(The next issue will be on May 17, 2010)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1Zqvx6uE7Vto5-3PfeA6gIh/

AlGahtani FH, Alshaikh M, and AlDiab A (2010) Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients. Ann Saudi Med 30:198-202.
http://www.ncbi.nlm.nih.gov/pubmed/20427935

Castoldi E, Maurissen LF, Tormene D, Spiezia L, Gavasso S, Radu C, Hackeng TM, Rosing J, and Simioni P (2010) Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III families. Haematologica
http://www.ncbi.nlm.nih.gov/pubmed/20421270

Ekser B and Cooper DK (2010) Overcoming the barriers to xenotransplantation: Prospects for the future. Expert Rev Clin Immunol 6:219-230.
http://www.ncbi.nlm.nih.gov/pubmed/20402385

Emiroglu O, Eyileten Z, Ucar T, and Ileri T (2010) Pediatric cardiac surgery under cardiopulmonary bypass in factor VII deficiency. Turk J Pediatr 52:101-103.
http://www.ncbi.nlm.nih.gov/pubmed/20402077

Godwin JW, Liem KF, Jr., and Brockes JP (2010) Tissue Factor expression in newt iris coincides with thrombin activation and lens regeneration. Mech Dev
http://www.ncbi.nlm.nih.gov/pubmed/20420902

Goksu S, Gul R, Ozen O, Yilmaz M, Buyukbebeci O, and Oner U (2010) Intravenous regional analgesia in a patient with Glanzmann thrombastenia. Middle East J Anesthesiol 20:589-591.
http://www.ncbi.nlm.nih.gov/pubmed/20394261

Grottke O, Henzler D, and Rossaint R (2010) Activated recombinant factor VII (rFVIIa). Best Pract Res Clin Anaesthesiol 24:95-106.
http://www.ncbi.nlm.nih.gov/pubmed/20402173

Kourtzelis I, Markiewski MM, Doumas M, Rafail S, Kambas K, et al. (2010) Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis. Blood
http://www.ncbi.nlm.nih.gov/pubmed/20424189

Kretz CA, Vaezzadeh N, and Gross PL (2010) Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 30:900-908.
http://www.ncbi.nlm.nih.gov/pubmed/20393156

Lechner D, Eichinger S, Wanivenhaus A, and Kyrle PA (2010) Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma - a rare indication for recombinant factor VIIa. Haemophilia
http://www.ncbi.nlm.nih.gov/pubmed/20398074

Martinet W, De Meyer I, Cools N, Timmerman V, Bult H, Bosmans J, and De Meyer GR (2010) Cell death-mediated cleavage of the attraction signal p43 in human atherosclerosis. Implications for plaque destabilization. Arterioscler Thromb Vasc Biol
http://www.ncbi.nlm.nih.gov/pubmed/20413730

McCunn M, Gordon EK, and Scott TH (2010) Anesthetic concerns in trauma victims requiring operative intervention: The patient too sick to anesthetize. Anesthesiol Clin 28:97-116.
http://www.ncbi.nlm.nih.gov/pubmed/20400043

Mei H, Shi W, Pang Z, Wang H, Lu W, Jiang X, Deng J, Guo T, and Hu Y (2010) EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery. Biomaterials
http://www.ncbi.nlm.nih.gov/pubmed/20413154

Morel O, Kessler L, Ohlmann P, and Bareiss P (2010) Diabetes and the platelet: Toward new therapeutic paradigms for diabetic atherothrombosis. Atherosclerosis
http://www.ncbi.nlm.nih.gov/pubmed/20394927

Ott H, Wiederholt T, Andresen Bergstrom M, Heise R, Skazik C, Czaja K, Marquardt Y, Karlberg AT, Merk HF, and Baron JM (2010) High-resolution transcriptional profiling of chemical-stimulated dendritic cells identifies immunogenic contact allergens, but not prohaptens. Skin Pharmacol Physiol 23:213-224.
http://www.ncbi.nlm.nih.gov/pubmed/20431333

Parent P, Trottier VJ, Bennett DR, Charlebois PB, and Schieff TD (2009) Are IVC filters required in combat support hospitals? J R Army Med Corps 155:210-212.
http://www.ncbi.nlm.nih.gov/pubmed/20397363

Pawlinski R, Wang JG, Owens AP, III, Williams J, Antoniak S, Tencati M, Luther T, Rowley JW, Low EN, Weyrich AS, and Mackman N (2010) Hematopoietic and non-hematopoietic cell tissue factor activates the
coagulation cascade in endotoxemic mice. Blood
http://www.ncbi.nlm.nih.gov/pubmed/20410508

Pinotti M, Bertolucci C, Frigato E, Branchini A, Cavallari N, Baba K, Contreras-Alcantara S, Ehlen C, Bernardi F, Paul KN, and Tosini G (2010) Chronic sleep deprivation markedly reduces coagulation factor VII expression. Haematologica
http://www.ncbi.nlm.nih.gov/pubmed/20418241

Shah AK, Banerjee D, Gambhir RP, and Chaudhry R (2009) Mallory-Weiss tear: Use of recombinant factor VIIa for exsanguinating bleed. Trop Gastroenterol 30:226-227.
http://www.ncbi.nlm.nih.gov/pubmed/20426286

Sniecinski RM, Chen EP, Makadia SS, Kikura M, Bolliger D, and Tanaka KA (2010) Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth
http://www.ncbi.nlm.nih.gov/pubmed/20430647

Sorensen B and Ingerslev J (2010) Platelet infusion supports recombinant factor VIIa in a patient with severe haemophilia A and inhibitor - Clinical outcome and laboratory observations. Thromb Haemost 103:
http://www.ncbi.nlm.nih.gov/pubmed/20431843

Spiezia L, Rossetto V, Campello E, Gavasso S, Woodhams B, Tormene D, and Simioni P (2010) Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. Thromb Haemost 103:
http://www.ncbi.nlm.nih.gov/pubmed/20431847

Strijbos MH, Gratama JW, Schmitz PI, Rao C, Onstenk W, Doyle GV, Miller MC, de Wit R, Terstappen LW, and Sleijfer S (2010) Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel. Eur J Cancer
http://www.ncbi.nlm.nih.gov/pubmed/20399640

Syburra T, Lachat M, Genoni M, and Wilhelm MJ (2010) Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation. Ann Thorac Surg 89:1643-1645.
http://www.ncbi.nlm.nih.gov/pubmed/20417801

Takano S, Yamashita T, and Ohneda O (2010) Molecular therapeutic targets for glioma angiogenesis. J Oncol 2010:351908
http://www.ncbi.nlm.nih.gov/pubmed/20414463

Toschi V and Baudo F (2010) Diagnosis, laboratory aspects and management of acquired hemophilia A. Intern Emerg Med
http://www.ncbi.nlm.nih.gov/pubmed/20407848

van Geest-Daalderop JH, Kraaijenhagen RJ, van der Meer FJ, and van den Besselaar AM (2010) Intraindividual variation of the International Normalized Ratio in patients monitored with a recombinant human thromboplastin. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20403089

Yuan ZH, Jiang JK, Huang WD, Pan J, Zhu JY, and Wang JZ (2010) A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia. J Clin Neurosci
http://www.ncbi.nlm.nih.gov/pubmed/20399668

Zakai NA, Lutsey PL, Folsom AR, Heckbert SR, and Cushman M (2010) Total tissue factor pathway inhibitor and venous thrombosis. The longitudinal investigation of thromboembolism aetiology. Thromb Haemost 104:
http://www.ncbi.nlm.nih.gov/pubmed/20431849
________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________